Independent research reference · 32 studies cited
Peptides for dogs, graded by the evidence that actually exists
Nine compounds. Canine-specific dosing, mechanisms, protocols and contraindications — with every claim traced to primary literature, and the gaps in that literature stated plainly rather than glossed over.
9
Compounds covered
13
Conditions
32
Studies cited
6
Canine-specific studies
The short answer
Peptides are short amino acid chains investigated in dogs for tissue repair, immune modulation, and muscle maintenance. None are FDA-approved for these purposes in dogs — all such use is off-label or investigational and legally requires veterinary supervision. The evidence base is uneven: BPC-157 has published canine pharmacokinetic and safety data, GHK-Cu has a canine wound-healing study, while compounds like PNC-27 and MGF have no companion animal data at all. Several compounds carry serious contraindications — TB-500, IGF-1 LR3 and MGF should not be used in dogs with cancer, and ivermectin can be fatal in dogs carrying the MDR1 gene mutation without prior genetic testing.
Start with a compound
Each profile covers mechanism, canine dosing by weight class, an example protocol, contraindications, and the studies behind every claim.
BPC-157
Emerging evidenceThe only peptide on this site with published canine pharmacokinetic data.
Read the full profile →TB-500
Emerging evidenceThe most established compound in veterinary research, with equine work dating to the early 2000s.
Read the full profile →Thymosin Alpha-1
Good evidenceApproved in more than 35 countries for human use as Zadaxin — the strongest evidence base on this site.
Read the full profile →GHK-Cu
Emerging evidenceA copper-binding tripeptide with a published canine wound-healing study.
Read the full profile →Or start with the problem
Which compounds are investigated for a given condition, and how strong that evidence actually is.
Hip dysplasia
A malformed hip joint that leads to instability, cartilage wear, and secondary arthritis, most common in large and giant breeds.
Osteoarthritis
Progressive cartilage loss and joint inflammation, affecting a large share of dogs over eight years old.
Cranial cruciate ligament (CCL) tear
Rupture of the stabilising ligament in the stifle, the single most common orthopaedic injury in dogs.
Intervertebral disc disease (IVDD)
Degeneration and herniation of spinal discs causing pain, weakness, or paralysis — a defining risk in chondrodystrophic breeds.
Wound healing
Repair of surgical incisions, lacerations, ulcers, and chronic non-healing wounds.
Post-surgical recovery
Supporting tissue repair, comfort, and return to function after an orthopaedic or soft tissue procedure.
How to read the evidence grades
Every compound on this site carries one of three grades. They describe the strength of published literature, not our confidence that something works.
Good evidence
Multiple studies in the target species, or approved for use in two or more countries, with published clinical data and a known safety profile. This does not mean "proven" — it means the evidence base is meaningfully established.
Emerging evidence
Some published data supports this use, but the evidence may be limited to a single species, a single study, preclinical models, or extrapolation from human and rodent data. Promising but incomplete.
Preliminary / in vitro only
Evidence is limited to cell culture, rodent models, or mechanistic reasoning. No companion animal data exists. Included for completeness of the research landscape, not as an endorsement.
Common questions
What are peptides and why are they used in dogs?+
Peptides are short chains of amino acids — smaller than proteins — that act as signalling molecules in the body. The compounds discussed in a canine context are mostly investigated for tissue repair, immune modulation, or muscle maintenance. None of them are FDA-approved for these uses in dogs; all such use is off-label or investigational and requires veterinary supervision.
Are peptides safe for dogs?+
Safety varies enormously by compound and cannot be generalised. BPC-157 has a preclinical safety evaluation finding no lethal dose in dogs. Ivermectin can be fatal in dogs carrying the MDR1 gene mutation. TB-500, IGF-1 LR3 and MGF are contraindicated in dogs with cancer. Each compound page on this site carries its own safety assessment rather than a blanket statement.
Which peptide has the most evidence in dogs specifically?+
BPC-157 has the only published canine pharmacokinetic study, conducted in beagles, alongside a dedicated preclinical safety evaluation. GHK-Cu has a veterinary surgical study on topical application to ischaemic open wounds in dogs. Ivermectin has an in vitro study using canine mammary tumour cells. Most other compounds rely on rodent, equine, or human data extrapolated to dogs.
Do I need a veterinarian to use peptides for my dog?+
Yes. In the United States, extralabel drug use in animals requires a valid veterinarian-client-patient relationship and the direct supervision of a licensed veterinarian under AMDUCA. Beyond the legal position, several compounds covered here require pre-treatment screening — an MDR1 genetic test before ivermectin, cancer screening before TB-500 or IGF-1 LR3, liver values before injectable GHK-Cu — that needs a veterinarian to order and interpret.
How is evidence graded on this site?+
Three grades. Good evidence means multiple studies in the target species or regulatory approval in two or more countries. Emerging evidence means some published data supports the use but it may rest on a single study or extrapolation from other species. Preliminary means cell culture, rodent models, or mechanism alone, with no companion animal data. The grade reflects the strength of published literature, not our opinion of whether a compound works.
New research, summarised monthly
Canine peptide research moves slowly and most of it never reaches pet owners. We read the new literature each month and send a short summary of anything that changes the picture — including findings that weaken a compound's case.
No more than one email a month. Unsubscribe at any time.
Where to source research peptides
Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.
Educational information — not veterinary medical advice
Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.